ClinicalTrials.Veeva

Menu

Efficacy of Naltrexone Treatment as Augmentation to SSRI in OCD Patients

S

Sheba Medical Center

Status

Completed

Conditions

Obsessive Compulsive Disorder

Treatments

Drug: Naltrexone

Study type

Interventional

Funder types

Other

Identifiers

NCT00234689
SHEBA-99-1897-JZ-CTIL

Details and patient eligibility

About

Assessing the efficacy of Naltrexone as augmentation to SSRI in patients with OCD

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of OCD
  • Treatment with SSRI for at least 10 weeks with no response

Exclusion criteria

  • Suffering from any medical condition
  • treatment with opiates
  • chronic use of drugs
  • Hepatitis or other liver related diseases
  • Incapability to sign an informed consent

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems